Johnson & Johnson JNJ

$285.75 +2.23 (0.79%)

Valuation

Market cap
687,888,896,000
Revenue TTM
$94,193,000,000
Net income TTM
$26,804,000,000
P/E (trailing)
26.62
P/E (forward)
25.50
Profit margin
28.46%
Debt to equity
0.44

Trading

Volume
6,291,200
Avg volume
7,238,710
Day's range
$281.68 – $288.11
Shares out
2,407,310,000
Stochastic %K
90%
Beta
0.22
Analysts
Moderate Buy
Price target
$281.64

Price

Company profile

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular...

Show more

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Industry
Drug Manufacturers - General
Sector
Healthcare
Phone
732 524 0400
Website
https://www.jnj.com
Address
One Johnson & Johnson Plaza, New Brunswick, United States

Latest news

Stocktwits

rocketwisher Nov 15, 7:37 PM
$JNJ just acquire SLS already you wuzz.
0 replies
Charles927 Nov 15, 7:14 PM 0 replies
clan2pointOh Nov 15, 5:47 PM
$ELTP Up 32% in a day constitutes a spike ... up. 👀 $TEVA 😲 $JNJ 🤑 $MRK 👀
0 replies
BullBoardTrend Nov 15, 3:04 PM
As of Friday's close: $JNJ's weekly has been green on ₿ull Board since 07/14/25 at $163.70, ~75% higher. Daily green too. No need to change your strategy. Our daily Telegram alerts flag confirmed trend flips on assets you already watch. Join the waitlist. Not financial advice.
0 replies
Acesjackson24 Nov 15, 1:23 AM
$BTC.X sell the crypto. Fade the Nasdaq. Everyone’s going to be begging for $PG amd $JNJ when this cycle plays out.
0 replies
PhantomZ Nov 14, 11:44 PM
$TLTFF $CGON $IBRX $ $JNJ A very good read….for NIMBC treatment comparison Theralase wins hands down if you ask me! It will one day be the 1st line treatment combined with other treatments significantly lowering overall treatments whilst increasing efficacy? No one beats a One and Done treatment! https://stockhouse.com/companies/bullboard?symbol=v.tlt&postid=37174712
4 replies
Gfywoody Nov 14, 11:15 PM
$JNJ Reddit Sellas followers encourage an all stock exchange of J&J to the tune of 40billy.
0 replies
viggizags Nov 14, 10:50 PM
$BTC.X for reals tho.....should have bought Woody Johnson coin, like for seriously $JNJ long woody Johnson short dem buttcoins. The ultimate pairs trade of the year. I said what what....i said what what.....I said what what.....
0 replies